Search bioRxiv⌕ Search

Biology subjects

Drezek, R. A.

Publications and source records attributed to Drezek, R. A..

3 recordsLinked to original sources

Expanded Multiplexing on Sensor-Constrained Microfluidic Partitioning Systems

Microfluidics can split samples into thousands or millions of partitions such as droplets or nanowells. Partitions capture analytes according to a Poisson distribution, and in diagnostics, the analyte concentration is commonly calculated with a closed-form solution via maximum likelihood estimation (MLE). Here, we present a generalization of MLE with microfluidics, an extension of our previously developed Sparse Poisson Recovery (SPoRe) algorithm, and an in vitro demonstration with droplet digital PCR (ddPCR) of the new capabilities that SPoRe enables. Many applications such as infection diagnostics require sensitive detection and broad-range multiplexing. Digital PCR coupled with conventional target-specific sensors yields the former but is constrained in multiplexing by the number of available measurement channels (e.g., fluorescence). In our demonstration, we circumvent these limitations by broadly amplifying bacteria with 16S ddPCR and assigning barcodes to nine pathogen genera using only five nonspecific probes. Moreover, we measure only two probes at a time in multiple groups of droplets given our two-channel ddPCR system. Although individual droplets are ambiguous in their bacterial content, our results show that the concentrations of bacteria in the sample can be uniquely recovered given the pooled distribution of partition measurements from all groups. We ultimately achieve stable quantification down to approximately 200 total copies of the 16S gene per sample, enabling a suite of clinical applications given a robust upstream microbial DNA extraction procedure. We develop new theory that generalizes the application of this framework to a broad class of realistic sensors and applications, and we prove scaling rules for system design to achieve further expanded multiplexing. This flexibility means that the core principles and capabilities demonstrated here can generalize to most biosensing applications with microfluidic partitioning.

bioengineering↗

Simulation-guided sloppy DNA probe design for mismatch-tolerant hybridization

The ability to both sensitively and specifically assess the sequence composition of a nucleic acid strand is an ever-growing field. Designing a detection scheme that can perform this function when the sequence of the target being detected deviates significantly from the canonical sequence however is difficult in part because probe/primer design is based on established Watson-Crick base-pairing rules. We present here a robust and tunable toehold-based exchange probe that can detect a sequence with a variable number of SNPs of unknown identity by inserting a series of controlled, sequential mismatches into the protector seal of the toehold probe, in an effort to make the protector seal "sloppy". We show that the mismatch tolerant system follows predicted behavior closely even with targets containing up to four mismatches and thermodynamically deviating from the canonical sequence by up to 15 kcal/mole. The system also performs faithfully regardless of the global mismatch position on either the protector seal or target. Lastly, we demonstrate the generalizability of the approach by testing the increasingly sloppy protectors on HIV clinical samples and show that the system is capable of resolving multiple, iteratively mutated sequences derived from numerous HIV sub-populations with remarkable precision.

bioengineering↗

Development of a Novel Class of Self-Assembling dsRNA Cancer Therapeutics: a Proof of Concept Investigation

Cancer has proven to be an extremely difficult challenge to treat. Several fundamental issues currently underlie cancer treatment including differentiating self from non-self, functional coupling of the recognition and therapeutic components of various therapies, and the propensity of cancerous cells to develop resistance to common treatment modalities via evolutionary pressure. Given these limitations, there is an increasing need to develop an all-encompassing therapeutic that can uniquely target malignant cells, decouple recognition from treatment, and overcome evolutionarily driven cancer resistance. We describe herein, a new class of programmable self-assembling dsRNA-based cancer therapeutics, that uniquely targets aberrant genetic sequences, and in a functionally decoupled manner, undergoes oncogenic RNA activated displacement (ORAD), initiating a therapeutic cascade that induces apoptosis and immune activation. As a proof-of-concept, we show that RNA strands targeting the EWS/Fli1 fusion gene in Ewing Sarcoma cells that are end-blocked with phosphorothioate bonds and additionally sealed with a 2-U modified DNA protector can be used to induce specific and potent killing of cells containing the target oncogenic sequence, but not wildtype.

bioengineering↗